Last updated on September 11th, 2021 at 08:16 am
The Health ministry in Kenya has began the coronavirus vaccine stage 1 clinical trials in the country, the ministry has been working tirelessly to develop a vaccine to combat the coronavirus pandemic that has affected the continent of Africa and the world.
Kenya has started stage 1 preliminaries of one of the main COVID-19 antibody applicants which have been created by the University of Oxford in organization with the drug organization, AstraZeneca.
Kenya sees stage 1 preliminaries of a Covid immunization up-and-comer created by the University of Oxford in organization with the drug organization, AstraZeneca.
In partnership with a university teaching hospital in the UK, they want to test the proposed drugs on over 50 coronavirus patient, so as to know the efficacy of the drug in the coronavirus fight. Other African countries has developed some supposed vaccines in the past but wasn’t approved by the WHO.
